Specific resistance to local graft-versus-host reaction in F1 hybrids pretreated intravenously with parent-strain spleen cells. Role of cytotoxic T lymphocytes directed against receptors for the major histocompatibility complex.
Pretreatment of B6D2F1 hybrids by injection of B6 spleen cells by subcutaneous or intravenous routes induces specific resistance to the local graft versus host reaction provoked by s.c. engraftment of B6 spleen cells. This resistance has been attributed to the presence in the pretreated F1 hybrids of cytotoxic T lymphocytes directed against receptors that recognize the D2 alloantigens (anti-D2-receptor CTL). However, this hypothesis would seem to be challenged, at least partially, by our previously published results showing that a) when tested before induction of GVHR, the anti-D2-receptor CTL are detectable in F1 hybrids pretreated only by the s.c. route but not by the i.v. route; and b) specific resistance to GVHR observed in i.v.-pretreated F1 hybrids is mediated by a nylon-adherent, Thy-1-, radioresistant (2000 rads) suppressor cell of B6 origin that does not manifest any anti-D2-receptor CTL activity. However, these results did not allow us to exclude the possibility of the presence, in the i.v.-pretreated F1 hybrids, of anti-D2-receptor precursor CTL that could be reactivated during the GVHR by the D2-receptors expressed on the proliferating clone of grafted B6 cells, then differentiate to the receptor-specific CTL effectors that control the development of the GVHR. That is why we have studied in the present work the CTL activity developed against D2-receptors after induction of GVHR in either normal or resistant F1 hybrids. Our results show that F1 hybrids protected against GVHR by i.v. pretreatment with B6 cells or by a transfer of nylon-adherent spleen cells from i.v.-pretreated syngeneic F1 mice do not manifest enhanced anti-D2-receptor CTL activity. When considered along with our previous observations, these results favor our hypothesis that anti-D2-receptor CTL are not involved in the specific resistance to GVHR observed in the i.v.-pretreated F1 hybrids.
Kosmatopoulos
K
K
INSERM U.267 Immunogénétique des Allogreffes, Villejuif, France.
Scott-Algara
D
D
Orbach-Arbouys
S
S
Halle-Pannenko
O
O
D000818:Animals; D006087:Graft vs Host Reaction; D006824:Hybridization, Genetic; D007113:Immunity, Innate; D008285:Major Histocompatibility Complex; D051379:Mice; D008815:Mice, Inbred Strains / Q000235:genetics; D011971:Receptors, Immunologic / Q000276:immunology; D013154:Spleen / Q000166:cytology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
D011971:Receptors, Immunologic